Inventor · disambiguated record
Grant Wishart
Also filed as: WISHART GRANT
25 granted patents·8 pending applications·91 citations·filing 2005–2024
94Inventor score
Top patents by PatentIndex Score
33 records- 0197US11034694B2Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 15, 2021·12 cites·22 claims
- 0296US11078201B2Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Aug 3, 2021·7 cites·22 claims
- 0396US11028085B2Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 8, 2021·6 cites·22 claims
- 0496US11021481B2Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 1, 2021·7 cites·22 claims
- 0595US11548890B1HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2021·Granted Jan 10, 2023·3 cites·30 claims
- 0691US8637507B2Bicyclic compounds as inhibitors of diacylglycerol acyltransferaseZHOU GANG·Filed 2010·Granted Jan 28, 2014·33 cites·4 claims
- 0788US11795165B2Tetrahydro-benzoazepine glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Oct 24, 2023·5 cites·12 claims
- 0886US12016852B2Pyrrolidine glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Jun 25, 2024·4 cites·16 claims
- 0986US11926625B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Granted Mar 12, 2024·1 cites·17 claims
- 1083US2024025898A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2023·Application pending·0 cites
- 1182US9617259B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Granted Apr 11, 2017·3 cites·39 claims
- 1275US12466841B2Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonistsNIMBUS SATURN INC·Filed 2023·Granted Nov 11, 2025·0 cites·24 claims
- 1375US7700634B2(Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptorORGANON NV·Filed 2005·Granted Apr 20, 2010·4 cites·14 claims
- 1474US10106535B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2017·Granted Oct 23, 2018·1 cites·18 claims
- 1573US10457675B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2018·Granted Oct 29, 2019·1 cites·20 claims
- 1672US12215105B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2020·Granted Feb 4, 2025·0 cites·18 claims
- 1772US2024199603A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2024·Application pending·0 cites
- 1871US9783488B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Granted Oct 10, 2017·1 cites·43 claims
- 1970US10053434B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2016·Granted Aug 21, 2018·1 cites·36 claims
- 2070US10047073B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2016·Granted Aug 14, 2018·1 cites·30 claims
- 2168US10065948B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2015·Granted Sep 4, 2018·1 cites·51 claims
- 2266US12071442B2Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonistsNIMBUS SATURN INC·Filed 2022·Granted Aug 27, 2024·0 cites·19 claims
- 2360US2025011331A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Application pending·0 cites
- 2455US12252488B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Granted Mar 18, 2025·0 cites·22 claims
- 2553US11685734B2ATM kinase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2020·Granted Jun 27, 2023·0 cites·35 claims
- 2649US2019185463A1Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2018·Application pending·0 cites
- 2749US2019202795A1Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2018·Application pending·0 cites
- 2844US2016031863A1Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Application pending·0 cites
- 2944US2010210680A1Tricyclic heterocyclic derivativesORGANON NV·Filed 2008·Application pending·0 cites
- 3043US7671080B21-benzylindole-2-carboxamide derivativesORGANON NV·Filed 2006·Granted Mar 2, 2010·0 cites·13 claims
- 3139US12202816B2Compounds as NADPH oxidase inhibitorsCALLIDITAS THERAPEUTICS SUISSE SA·Filed 2019·Granted Jan 21, 2025·0 cites·21 claims
- 3232US2012258957A1Heterocyclic derivativesBINGHAM MATILDA JANE·Filed 2010·Application pending·0 cites
- 3320US8729274B2Tricyclic heterocyclic derivativesDAVIES KENETH·Filed 2010·Granted May 20, 2014·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Grant Wishart files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →